Permatage XT Settable Bone Putty— 510(k) K261265

Substantially Equivalent

Orthocon, Inc.

FDA 510(k) clearance K261265 for Permatage XT Settable Bone Putty, Substantially Equivalent on 2026-06-15. Applicant: Orthocon, Inc.. Device class: 2.

Summary

Orthocon's Permatage XT Settable Bone Putty is filed under GXP, methyl methacrylate for cranioplasty. The settable description comes from the device name; the record doesn't give the putty's composition.

Class II, 21 CFR 882.5300. Neurology is both the classification panel and the review panel, and it came in as a Special 510(k).

Orthocon filed from Stamford, Connecticut. The decision came 60 calendar days after FDA received it (April 16 to June 15, 2026).

Clearance details

Applicant
Orthocon, Inc.
Product code
Product code GXP
Device class
Class 2
Regulation
21 CFR 882.5300
Advisory panel
Neurology
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Special
Location
Stamford, CT, US
Download summary PDFView on FDA.gov ↗

Recent devices under product code GXP

view all

More clearances from Orthocon, Inc.

view all

Data sourced from openFDA. This site is unofficial and independent of the FDA.